Dr. Reddy's Laboratories Limited reported INR 325.5B of revenue over the trailing twelve months, +72% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: INR 325.5B (to FY2025). Net Income: INR 56.5B, trailing twelve months to FY2025. Free Cash Flow: INR 18.9B, trailing twelve months to FY2025. Op Margin: 22%, trailing twelve months to FY2025.

RDYDr. Reddy's Laboratories Limited

HealthcareUSD

$12.22

$11.4052 weeks$15.25

RDY as reported

Dr. Reddy's Laboratories Limited reported INR 325.5B of revenue over the trailing twelve months, +72% on the year before. 10 reported series are charted on this page, each one as filed.

INR 325.5B

Revenue, trailing twelve months · to FY2025 · +72% against the twelve months before

Net Income: INR 56.5B
Net Income · +228% year on year · trailing twelve months to FY2025
Free Cash Flow: INR 18.9B
Free Cash Flow · −27% year on year · trailing twelve months to FY2025
Op Margin: 22%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for RDY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	INR 325.5B	+72%	FY2025
Net Income	INR 56.5B	+228%	FY2025
EPS	INR 0.79	−99%	FY2025
Gross Margin	58%	n/a	FY2025
Op Margin	22%	n/a	FY2025
Net Margin	17%	n/a	FY2025
ROE	17%	n/a	FY2025
ROA	11%	n/a	FY2025
ROIC	15%	n/a	FY2025
Free Cash Flow	INR 18.9B	−27%	FY2025